Continuous release of endostatin from microencapsulated engineered cells for tumor therapy.
about
Inhibition of medulloblastoma cell invasion by SlitTissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapyElectrohydrodynamic atomization: A two-decade effort to produce and process micro-/nanoparticulate materialsColloidosomes: selectively permeable capsules composed of colloidal particlesLack of collagen XVIII/endostatin results in eye abnormalitiesCore-shell hydrogel microcapsules for improved islets encapsulation.Preparation and in vitro studies of microencapsulated cells releasing human tissue inhibitor of metalloproteinase-2.Anti-tumor therapy with macroencapsulated endostatin producer cells.Alginate composition effects on a neural stem cell-seeded scaffoldRose bengal-grafted biodegradable microcapsules: singlet-oxygen generation and cancer-cell incapacitation.Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.Microencapsulation of small intestinal neuroendocrine neoplasm cells for tumor model studiesGeneration of histocompatible tissues using nuclear transplantation.Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors.Stem cells: the next therapeutic frontier.Cellular actions and signaling by endostatin.hMSC-mediated concurrent delivery of endostatin and carboxylesterase to mouse xenografts suppresses glioma initiation and recurrence.Delivery of endostatin in experimental cancer therapy.Local delivery of a synthetic endostatin fragment for the treatment of experimental gliomasProgress and challenges for cell encapsulation in brain tumour therapy.Induction of erythropoiesis using human vascular networks genetically engineered for controlled erythropoietin releaseMolecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis.Tissue engineering for the replacement of organ function in the genitourinary system.Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigationEndogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapyAngiogenesis with biomaterial-based drug- and cell-delivery systems.Progress report on the potential of angiogenesis inhibitors for neuro-oncology.Therapeutic applications of polymeric artificial cells.Continuous release of interleukin 12 from microencapsulated engineered cells for colon cancer therapy.Tissue engineering, stem cells and cloning: current concepts and changing trends.Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengersAntiangiogenic therapy in brain tumors.Novel technologies for antiangiogenic drug delivery in the brain.Release of tissue inhibitor of metalloproteinase-2 from alginate microcapsule encapsulating genetically engineered cells.The structure and dynamics of Nano Particles encapsulated by the SDS monolayer collapse at the water/TCE interfaceMicrofabrication of homogenous, asymmetric cell-laden hydrogel capsules."Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment.Development of cationic polymer coatings to regulate foreign-body responses.Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy.Nano to micro delivery systems: targeting angiogenesis in brain tumors.
P2860
Q24680387-C413E6DE-B41C-4842-B410-4E1284F00BA8Q24809660-A3BEFE1A-E8B4-443C-8F0E-FD4E6E02D7B3Q27319315-887EECE5-F7E4-4579-80FC-EACC4E6DD7C1Q28212757-22373800-4EEF-4C99-9594-D48E7A6DCA82Q28511317-8D775387-24BA-4995-A6EE-BC7C68411150Q30439009-F1B22D18-02BC-4AEC-8545-C5A732404833Q33222560-5344C343-1887-4C7E-BE07-D877014EDD31Q33536136-C19A0213-11AA-4A84-B31D-EF003D9AB9B1Q33643851-F363CF99-D45A-4344-B5B8-802FCD579ACAQ33997405-504211A1-FFF2-4115-8FB9-EEADEAFC9046Q34130059-CCCC42AB-39F2-426D-9FC6-5A966011599EQ34204609-8F84A840-E9C8-4724-B486-102AC2D4E222Q34524710-CC0D189F-2647-4D8B-844B-439ABEFC9C0AQ34588908-13484475-0514-446F-8CA4-5FE49E647C48Q34655082-A2285EC4-71BC-422B-AB65-89CA6849F052Q35008096-775CF2FD-B557-46DF-8FF7-97308272695DQ35086702-448696AA-0489-48F3-8F58-3622D63CDA71Q35092178-87B4E634-4BF7-491C-A8D6-D8E9993505F8Q35127230-EECF6078-1378-4157-AE6A-C9821C102594Q35164781-B4669615-9168-4193-ADC4-0FC5D3189BDDQ35553300-E24F265B-2D15-4CA1-B162-BACBC1A8F4D0Q35641225-99913799-D093-41F8-950F-9DB2B01FC7DAQ35661050-86ED4504-8971-459B-983D-D9AAEF45E08AQ35695799-C3D870CE-9F48-4C94-A232-6BEB904B411FQ35800448-4FDFE354-540D-465E-9424-525AF8C93ADAQ35837499-43EC7707-8414-4DCE-8E5B-95D22874115FQ35964419-8DCD18EF-5C7E-47FB-9675-E484B1560E53Q36058455-71626545-3419-4CBD-89D8-604EB2E1AFC1Q36178555-F617169B-657E-4502-AEA8-593F621F4CCAQ36194058-C55C8E6C-2FC1-4FE1-BB96-789C7B0A0D8DQ36578668-35E3CD4F-B312-4BA0-B92E-A461AB10B977Q37129915-4676D067-6965-42F8-9DD4-903B0163ACE2Q37186246-16CB746C-EA38-4FBA-9DA9-08E42C6067B9Q37305553-6644E837-8AE7-4458-8205-F1067BDB8A62Q37419214-93D76C67-4ABA-45C1-A814-37A7C9837A19Q37594551-AEC9A777-5CF9-4A05-A07F-CCE9E5660408Q37622288-B9E6E8EE-89A6-45E6-B6FE-9DD5D86739D6Q37642549-17D9E23F-5B8A-467C-BE1E-1F6C4BFF2C93Q37707063-AFCD5BBE-0368-4142-B7C4-280F0ECCB0D5Q37798870-9B1AD36C-CEBA-41DE-8AA3-F6C251EBD9DD
P2860
Continuous release of endostatin from microencapsulated engineered cells for tumor therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Continuous release of endostat ...... eered cells for tumor therapy.
@ast
Continuous release of endostat ...... eered cells for tumor therapy.
@en
type
label
Continuous release of endostat ...... eered cells for tumor therapy.
@ast
Continuous release of endostat ...... eered cells for tumor therapy.
@en
prefLabel
Continuous release of endostat ...... eered cells for tumor therapy.
@ast
Continuous release of endostat ...... eered cells for tumor therapy.
@en
P2093
P356
P1433
P1476
Continuous release of endostat ...... eered cells for tumor therapy.
@en
P2093
Carroll RS
Seyfried NT
P2888
P356
10.1038/83481
P577
2001-01-01T00:00:00Z
P5875
P6179
1000123821